Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol.
Saved in:
| Title: | Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol. |
|---|---|
| Authors: | Ghonem NS; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA., Auclair AM; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA., Hemme CL; RI-INBRE Bioinformatics Core, University of Rhode Island, Kingston, Rhode Island, USA., Gallucci GM; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA., de la Rosa Rodriguez R; Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA., Boyer JL; Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA., Assis DN; Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Dec; Vol. 108 (6), pp. 1213-1223. Date of Electronic Publication: 2020 Jul 17. |
| Publication Type: | Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32480421 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ghonem+NS%22">Ghonem NS</searchLink>; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Auclair+AM%22">Auclair AM</searchLink>; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Hemme+CL%22">Hemme CL</searchLink>; RI-INBRE Bioinformatics Core, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22Gallucci+GM%22">Gallucci GM</searchLink>; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.<br /><searchLink fieldCode="AU" term="%22de+la+Rosa+Rodriguez+R%22">de la Rosa Rodriguez R</searchLink>; Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Boyer+JL%22">Boyer JL</searchLink>; Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Assis+DN%22">Assis DN</searchLink>; Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2020 Dec; Vol. 108 (6), pp. 1213-1223. <i>Date of Electronic Publication: </i>2020 Jul 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32480421 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.1930 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1213 Titles: – TitleFull: Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ghonem NS – PersonEntity: Name: NameFull: Auclair AM – PersonEntity: Name: NameFull: Hemme CL – PersonEntity: Name: NameFull: Gallucci GM – PersonEntity: Name: NameFull: de la Rosa Rodriguez R – PersonEntity: Name: NameFull: Boyer JL – PersonEntity: Name: NameFull: Assis DN IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2020 Dec Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 108 – Type: issue Value: 6 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |
